MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Novel KCND3 mutation associated with paroxysmal motor exacerbations in spinocerebellar ataxia 19

M. Paucar, R. Ågren, T. Li, S. Lissmats, Å. Bergendal, I. Savitcheva, D. Nilsson, K. Sahlholm, P. Svenningsson, J. Nilsson (Stockholm, Sweden)

Meeting: MDS Virtual Congress 2020

Abstract Number: 49

Keywords: Ataxia: Etiology and Pathogenesis, Ataxia: Genetics

Category: Ataxia

Objective: To investigate a family affected by ataxia and paroxysmal motor exacerbations.

Background: Ataxia channelopathies share common traits such as slow progression and variable degree of cognitive impairment. Heterozygous mutations in KCND3, encoding K channel Kv4.3, are associated with the rare spinocerebellar ataxia 19 (SCA19) allelic with spinocerebellar ataxia 22 (SCA22). Some patients with mutations in KCND3 can present with cardiac arrhythmia. In the other hand, mutations in KCNC3, encoding Kv3.3, cause spinocerebellar ataxia 13 (SCA13).

Method: Comprehensive clinical and psychometric evaluation, neuroimaging and genotyping of a Swedish family (mother and son) affected by ataxia was carried out. Heterozygous and homozygous Kv3.3 A671V and Kv4.3 V374A variants were evaluated in Xenopus laevis oocytes using high-throughput, two-electrode voltage-clamp. Implications of modified Kv4 conductance on neuronal activity were investigated computationally using an established Purkinje neuron model.

Results: Adult-onset slowly progressive cerebellar ataxia with cognitive difficulties are the main findings in this family. Exacerbations occurred in the index case when he was exposed to sudden speed changes such as riding an elevator or trains. Treatment with acetazolamide (ACZ) attenuated these paroxysmal exacerbations. Both patients had attended special schools, their IQ ranged between 90-95. Despite these deficits, FDG-PET displayed hypometabolism only in the marked atrophic cerebellum in both cases. Genetic analyses revealed the new variant c.1121T>C (V374A) in KCND3 and c.2012T>C (A671V) in KCNC3. The latter has a MAF of 0.02%. A synergistic effect between both variants was suspected. However, reduced currents of Kv4.3 V374A, but not of Kv3.3 A671V, were observed, consistent with a dominant negative effect. Computational modeling suggested an increase in Purkinje neuron firing frequency based on the reduced Kv4.3 V374A current. Finally, we did not find evidence of cardiac arrhythmia.

Conclusion: Our findings demonstrate a pathogenic role for the novel variant Kv4.3 V374A. The index case displays paroxysmal ataxia exacerbation attenuated with ACZ which are new traits for SCA19/22. In addition, despite intellectual disability FDG-PET demonstrated hypometabolism limited to the atrophic cerebellum suggesting compensatory pathways.

To cite this abstract in AMA style:

M. Paucar, R. Ågren, T. Li, S. Lissmats, Å. Bergendal, I. Savitcheva, D. Nilsson, K. Sahlholm, P. Svenningsson, J. Nilsson. Novel KCND3 mutation associated with paroxysmal motor exacerbations in spinocerebellar ataxia 19 [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/novel-kcnd3-mutation-associated-with-paroxysmal-motor-exacerbations-in-spinocerebellar-ataxia-19/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/novel-kcnd3-mutation-associated-with-paroxysmal-motor-exacerbations-in-spinocerebellar-ataxia-19/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley